Related Experiment Video
Updated: Feb 4, 2026

Adjustable Stiffness, External Fixator for the Rat Femur Osteotomy and Segmental Bone Defect Models
Published on: October 9, 2014
Localized low-dose rhBMP-2 is effective at promoting bone regeneration in mandibular segmental defects.
Patricia Carlisle1, Teja Guda2, David T Silliman1
1Department of Craniomaxillofacial Regenerative Medicine, Dental and Trauma Research Detachment, Fort Sam Houston, Texas, 78234.
Low-dose recombinant human bone morphogenetic protein 2 (rhBMP-2) effectively promotes bone regeneration in mandibular defects. This study found reduced complications, suggesting improved safety for craniomaxillofacial injuries.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Orthopedic Surgery
Background:
- Craniomaxillofacial (CMF) injuries represent a significant portion of battlefield wounds.
- Recombinant human bone morphogenetic protein 2 (rhBMP-2) is utilized for CMF open fracture treatment, but associated complications exist.
- Investigating lower rhBMP-2 doses may enhance safety profiles for CMF fracture treatment.
Purpose of the Study:
- To evaluate the efficacy and safety of a reduced dose (30% recommended) of rhBMP-2 for treating mandibular fractures.
- To assess bone regeneration and inflammatory responses in a minipig model with segmental mandibular defects.
Main Methods:
- rhBMP-2 was delivered using a polyurethane (PUR) and hydroxyapatite/β-tricalcium phosphate (Mastergraft®) scaffold.
- Minipigs with 2 cm segmental mandibular defects were used, with bone regeneration analyzed via CT scans at 4, 8, and 12 weeks.
- Serum and drain effluent were analyzed for inflammatory marker concentrations.
Main Results:
- Complete bone bridging was observed in the PUR-Mastergraft® + rhBMP-2 group, versus incomplete bridging in controls.
- Volumetric analysis showed significantly more regenerated bone in the rhBMP-2 treated group from 4 to 12 weeks.
- Inflammatory markers varied locally in drain effluent and saliva but not serum, with no excessive increase in the rhBMP-2 group.
Conclusions:
- Low-dose rhBMP-2 delivered via a PUR-Mastergraft® scaffold significantly enhances bone regeneration in mandibular defects.
- The treatment restored bone quality without inducing excessive inflammatory responses, suggesting improved safety.
- These findings support the potential of low-dose rhBMP-2 as an efficacious and safer option for CMF open fracture treatment.
More Related Videos
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Lumber Defects
Shakes are minor fractures that run along or across the wood's annual rings, while wane is...
Biological Effects of Radiation

